[1] 吴唯, 吕新生, 唐中华, 李小荣, 陈道瑾, WU Wei, LU Xin-sheng, TANG Zhong-hua, LI Xiao-rong, CHEN Dao-jin. 乳腺癌组织中PSA mRNA的表达及其与ER亚型表达的关系 [J]. 中国普通外科杂志 2006.doi:10.3969/j.issn.1005-6947.2006.04.006 [2] 刘铁成, 鲁智, 陶仪声, 佘明金, 王勤. 乳腺癌pS2、PSA表达与ER、PR的关系及预后意义 [J]. 蚌埠医学院学报 2004.doi:10.3969/j.issn.1000-2200.2004.06.004 [3] 张淑群, 强水云, 王西京, 纪宗正, 李妙羡. 血清T-PSA和F-PSA检测在乳腺癌诊断中的意义 [J]. 中国肿瘤临床 2004.doi:10.3969/j.issn.1000-8179.2004.17.012 [4] 劳明, 潘忠勉, 黄文成, 黄玲莎, 张其进, 雷考宁. 血清T-PSA及F-PSA检测对乳腺癌的诊断价值 [J]. 肿瘤防治研究 2007.doi:10.3971/j.issn.1000-8578.2007.01.027 [5] Bassily, NH, Vallorosi, CJ, Akdas, G, Montie, JE, Rubin, MA. Coordinate expression of cytokeratins 7 and 20 in prostate adenocarcinoma and bladder urothelial carcinoma. [J]. American Journal of Clinical Pathology 2000, 3(3). [6] Mannello F, Gazzanelli. Prostate-specific antigen:a further player in the field of breast cancer diagnosis [J]. Breast Cancer Research 2001, 3(04). [7] Diamandis E P, Yousef G M, Luo L Y. The new human kallikrein gene family:implication in carcinogenesis [J]. Trend End Met 2000, 11(02). [8] Diamandis E P, Yousef G M. Human tissue kallikreins:a family of new cancer biomarkers [J]. Clinical Chemistry 2002, 48(08). [9] 刘铁成, 李德春, 陶仪声, LIU Tie-cheng, LI De-chun, TAO Yi-sheng. 乳腺癌中pS2与PSA相关性的研究 [J]. 中华全科医学 2009. |